home All News open_in_new Full Article

Empfindlicher Rückschlag: Pfizer stoppt Entwicklung von Abnehmpille

Der US-Pharmakonzern Pfizer begräbt seine Pläne zur Entwicklung eines Abnehmpräparats namens Danuglipron. Der Aktienmarkt reagiert unbarmherzig.


today 32 h. ago attach_file Society

attach_file Society
attach_file Society
attach_file Society
attach_file Society
attach_file Politics
attach_file Society
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Society
attach_file Society
attach_file Society
attach_file Economics
attach_file Society
attach_file Politics
attach_file Society


ID: 356643670
Add Watch Country

arrow_drop_down